P4 Diagnostix, a network of diagnostic testing labs, announced this week it has acquired the assets of Strand Diagnostics. The buy includes Strand’s Know Error system for forensic DNA testing, and its UroSeq testing panel for advanced prostate cancer. In an email, P4 Diagnostix VP of Business Development Brett Reilly declined to disclose the terms of the deal. He said that the majority of Strand’s employees will be offered employment with P4 Diagnostix, which is based in Beltsville, Maryland. It also has labs in New York, New Jersey, Virginia, Georgia, North Carolina, and Arizona. All key operation members of Strand are being retained, Reilly said, and Strand will remain in Indianapolis.